Swiss National Bank’s Otonomy, Inc. OTIC Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2017
Q4
Sell
-41,400
Closed -$135K 2543
2017
Q3
$135K Hold
41,400
﹤0.01% 2522
2017
Q2
$780K Buy
41,400
+6,600
+19% +$92K ﹤0.01% 2196
2017
Q1
$426K Buy
34,800
+2,700
+8% +$39.3K ﹤0.01% 2419
2016
Q4
$510K Hold
32,100
﹤0.01% 2387
2016
Q3
$584K Hold
32,100
﹤0.01% 2274
2016
Q2
$510K Hold
32,100
﹤0.01% 2342
2016
Q1
$461K Buy
32,100
+14,200
+79% +$223K ﹤0.01% 2351
2015
Q4
$497K Hold
17,900
﹤0.01% 2268
2015
Q3
$319K Buy
17,900
+2,400
+15% +$56.8K ﹤0.01% 2378
2015
Q2
$356K Buy
15,500
+3,400
+28% +$95.4K ﹤0.01% 2387
2015
Q1
$428K Buy
12,100
+6,900
+133% +$236K ﹤0.01% 2248
2014
Q4
$173K Buy
+5,200
New +$139K ﹤0.01% 2533

Other funds holding OTIC

Swiss National Bank's OTIC Position: Q4 2017 in Review

Swiss National Bank sold out of Otonomy, Inc. (OTIC) in Q4 2017, closing a stake of 41,400 shares — an estimated $135K sold.

Swiss National Bank first reported a position in OTIC in Q4 2014 and held it in 12 quarters. The position peaked at $780K in Q2 2017. 83 funds tracked by Wall St. Rank hold OTIC as of Q4 2017.

  • Swiss National Bank reported no remaining Otonomy, Inc. position as of Q4 2017 after selling out during the quarter.
  • Swiss National Bank sold 41,400 Otonomy, Inc. shares in Q4 2017, an estimated $135K.
  • Swiss National Bank first reported a position in Otonomy, Inc. in Q4 2014 and held it in 12 quarters.
  • Swiss National Bank's Otonomy, Inc. position peaked at $780K in Q2 2017.
  • 83 funds tracked by Wall St. Rank held Otonomy, Inc. as of Q4 2017.

Based on Swiss National Bank's 13F filing for Q4 2017, filed 7 Feb 2018.